Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3320 participants.

Also called NCT04416581

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 3,320 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04416581
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04416581. Randomized; quadruple masking; primary purpose prevention. Start 2021-05-12 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
Acronym
PROTECT-HBR
Condition
Acute Coronary Syndrome
Intervention (Drug)
PPI
Intervention (Drug)
P-CAB 50
Lead sponsor
Duk-Woo Park, MD (class: other)

Record details

Record id
cardio:ct-nct04416581
Content hash
87e2d0f0e9757265289c92a2b1041277a96bd3eeff63792c054b0530dc020fe9